Maze Therapeutics Announces Pricing of Upsized Initial Public Offering

CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options

Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer

ARTBIO Announces Appointment of Nicole Hadas as Chief Legal Officer

Marea Therapeutics Forms Clinical Scientific Advisory Board